Baricitinib or Tocilizumab? Treatment of Patients Hospitalized With Severe COVID-19.
| Autor: | Cawcutt KA; Both authors: Department of Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE., Kalil AC |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Critical care medicine [Crit Care Med] 2023 Mar 01; Vol. 51 (3), pp. 413-415. Date of Electronic Publication: 2023 Feb 21. |
| DOI: | 10.1097/CCM.0000000000005757 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|